Investigators have developed a Uveal Melanoma Immunogenomic Score (UMIS) to predict which patients with metastatic uveal melanoma will respond to immunotherapy, according to findings published in Nature Communications.
2024
Dr Olson on the Potential Benefit of Lifileucel in Relapsed/Refractory Metastatic Melanoma
Daniel Olson, MD, assistant professor, medicine, the University of Chicago Medical Center, UChicago Medicine, discusses the benefit associated with lifileucel (Amtagvi) in patients with unresectable or metastatic melanoma, highlighting patients likely to derive the most benefit from this treatment approach.
Australian of the Year Richard Scolyer ‘blown away’ by success of radical new brain cancer treatment
World-first clinical trials of a groundbreaking treatment for aggressive brain tumours are likely to begin soon following “fantastic" results in the high-profile case of Australian of the Year, Professor Richard Scolyer.
Men With Melanoma Who Receive Enhanced Vaccine Experience Improvements in Overall Survival
It is unclear why the vaccines were less effective in women, but researchers note that the findings can be important when determining immune therapy outcomes in patients with melanoma.